{"transactions":[{"id":700558,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-30T20:32:12.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock, which vest on July 28, 2027."}],"balance_after":29825,"source":{"system":"sec-edgar","filing":"0001437749-26-025078","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203467/000143774926025078/rdgdoc.xml","form_type":"4"}},{"id":1022028,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-10-07T20:10:29.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock, which vest on October 3, 2026."}],"balance_after":19825,"source":{"system":"sec-edgar","filing":"0001437749-25-030639","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203467/000143774925030639/rdgdoc.xml","form_type":"4"}},{"id":1371172,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true}}],"security":"Common Shares","published_at":"2024-11-09T00:37:55.000Z","date":"2024-11-06","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares, which vest on the earlier of November 6, 2025, or at the Issuer's next annual stockholder meeting."}],"balance_after":9825,"source":{"system":"sec-edgar","filing":"0000912282-24-000754","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203467/000091228224000754/form4.xml","form_type":"4"}},{"id":1371170,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true}}],"security":"Common Shares","published_at":"2024-11-09T00:32:43.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares, which vest as follows:  1/3 on August 11, 2024, with the remaining restricted shares vesting in eight equal installments every three months beginning November 11, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects 1-for-20 reverse stock split effected by the Issuer on January 6, 2023."}],"balance_after":8325,"source":{"system":"sec-edgar","filing":"0000912282-24-000752","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203467/000091228224000752/form4.xml","form_type":"4/A","original_submission_date":"2023-08-15"}},{"id":1807106,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true}}],"security":"Common Shares","published_at":"2023-08-15T23:44:39.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares, which vest as follows:  1/3 on August 11, 2024, with the remaining restricted shares vesting in eight equal installments every three months beginning on November 11, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects 1-for-20 reverse stock split effected by the Issuer on January 6, 2023."}],"balance_after":1841,"source":{"system":"sec-edgar","filing":"0000912282-23-000302","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203467/000091228223000302/form4.xml","form_type":"4"}},{"id":2022420,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-02-10T23:13:33.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share grant.  One-third of the restricted shares shall vest on July 1, 2023; the remaining restricted shares shall vest quarterly thereafter, at 1/8th of the remaining grant, with full vesting on July 1, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total reflects 1-to-20 reverse stock split effected by the Issuer on January 6, 2023."}],"balance_after":6825,"source":{"system":"sec-edgar","filing":"0001567619-23-002409","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203467/000156761923002409/doc1.xml","form_type":"4"}},{"id":2216880,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-07-01T19:12:37.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represented restricted share grant.  One-third of the restricted shares shall vest on July 1, 2023; the remaining restricted shares shall vest quarterly thereafter, at 1/8th of the remaining grant, with full vesting on July 1, 2025."}],"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001567619-22-013590","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203467/000156761922013590/doc1.xml","form_type":"4"}},{"id":3316204,"issuer":{"id":151567,"kind":"organization","name":"INNOVUS PHARMACEUTICALS, INC.","symbol":"INNV"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-01-07T20:04:51.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":10112,"price":0.89,"value":8999.68,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted a Restricted Stock Unit on January 2, 2020 of 10,112 shares, which were fully vested on the date of the grant.  The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the fourth quarter of 2020 and was valued on December 31, 2019 in accordance with the approved compensation plan for the non-employee members of the Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan."}],"balance_after":42902,"derivative":{"exercise_date":"2020-01-02","expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":10112},"source":{"system":"sec-edgar","filing":"0001437749-20-000323","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411879/000143774920000323/rdgdoc.xml","form_type":"4"}},{"id":3400875,"issuer":{"id":151567,"kind":"organization","name":"INNOVUS PHARMACEUTICALS, INC.","symbol":"INNV"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-10-02T20:47:10.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":4286,"price":2.1,"value":9000.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted a Restricted Stock Unit on October 1, 2019 of 4,286 shares, which were fully vested on the date of the grant.  The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the third quarter of 2019 and was valued on September 30, 2019 in accordance with the approved compensation plan for the non-employee members of the Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan."}],"balance_after":32790,"derivative":{"exercise_date":"2019-10-01","expiration_date":"2029-10-01","underlying":"Common Stock","underlying_shares":4286},"source":{"system":"sec-edgar","filing":"0001437749-19-019543","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411879/000143774919019543/rdgdoc.xml","form_type":"4"}},{"id":3467815,"issuer":{"id":151567,"kind":"organization","name":"INNOVUS PHARMACEUTICALS, INC.","symbol":"INNV"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-07-03T12:01:10.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":3948,"price":1.52,"value":6000.96,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted a Restricted Stock Unit on July 1, 2019 of 3,948 shares, which were fully vested on the date of the grant.  The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the second quarter of 2019 and was valued on June 28, 2019 in accordance with the approved compensation plan for the non-employee members of the Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan."}],"balance_after":28504,"derivative":{"exercise_date":"2019-07-01","expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":3948},"source":{"system":"sec-edgar","filing":"0001437749-19-013454","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411879/000143774919013454/rdgdoc.xml","form_type":"4"}},{"id":3568361,"issuer":{"id":151567,"kind":"organization","name":"INNOVUS PHARMACEUTICALS, INC.","symbol":"INNV"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-04-02T19:27:39.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":1095,"price":5.48,"value":6000.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted a Restricted Stock Unit on April 1, 2019 of 1,095 shares, which were fully vested on the date of the grant.  The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the first quarter of 2019 and was valued on March 29, 2019 in accordance with the approved compensation plan for the non-employee members of the Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan."}],"balance_after":24556,"derivative":{"exercise_date":"2019-04-01","expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":1095},"source":{"system":"sec-edgar","filing":"0001437749-19-006429","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411879/000143774919006429/rdgdoc.xml","form_type":"4"}},{"id":3703743,"issuer":{"id":151567,"kind":"organization","name":"INNOVUS PHARMACEUTICALS, INC.","symbol":"INNV"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-01-04T15:42:38.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":89552,"price":0.067,"value":5999.984,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted a Restricted Stock Unit on January 2, 2019 of 89,552 shares, which were fully vested on the date of the grant.  The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the fourth quarter of 2018 and was valued on December 31, 2018 in accordance with the approved compensation plan for the non-employee members of the Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan."}],"balance_after":2461314,"derivative":{"exercise_date":"2019-01-02","expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":89552},"source":{"system":"sec-edgar","filing":"0001437749-19-000338","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411879/000143774919000338/rdgdoc.xml","form_type":"4"}},{"id":3801053,"issuer":{"id":151567,"kind":"organization","name":"INNOVUS PHARMACEUTICALS, INC.","symbol":"INNV"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2018-10-02T16:56:17.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":50000,"price":0.12,"value":6000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted a Restricted Stock Unit on October 1, 2018 of 50,000 shares, which were fully vested on the date of the grant. The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the third quarter of 2018 and was valued on September 30, 2018 in accordance with the approved compensation plan for the non-employee members of the Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan."}],"balance_after":2371762,"derivative":{"exercise_date":"2018-10-01","expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-18-017793","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411879/000143774918017793/rdgdoc.xml","form_type":"4"}},{"id":3864413,"issuer":{"id":151567,"kind":"organization","name":"INNOVUS PHARMACEUTICALS, INC.","symbol":"INNV"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-07-19T15:00:06.000Z","date":"2018-07-01","kind":"grant","acquired":true,"shares":54545,"price":0.11,"value":5999.95,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted a Restricted Stock Unit on July 1, 2018 of 54,545 shares, which were fully vested on the date of the grant.  The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the second quarter of 2018 and was valued on June 30, 2018 in accordance with the approved compensation plan for the non-employee members of the Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan."}],"balance_after":2321762,"derivative":{"exercise_date":"2018-07-01","expiration_date":"2028-07-01","underlying":"Common Stock","underlying_shares":54545},"source":{"system":"sec-edgar","filing":"0001415889-18-001141","document":"form4-07192018_110750.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411879/000141588918001141/form4-07192018_110750.xml","form_type":"4"}},{"id":3972595,"issuer":{"id":151567,"kind":"organization","name":"INNOVUS PHARMACEUTICALS, INC.","symbol":"INNV"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-04-03T16:25:30.000Z","date":"2018-04-01","kind":"grant","acquired":true,"shares":49059,"price":0.1223,"value":5999.9157,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted a Restricted Stock Unit on April 1, 2018 of 49,059 shares, which were fully vested on the date of the grant.  The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the first quarter of 2018 and was valued on March 30, 2018 in accordance with the approved compensation plan for the non-employee members of the Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan."}],"balance_after":2267217,"derivative":{"exercise_date":"2018-04-01","expiration_date":"2028-04-01","underlying":"Common Stock","underlying_shares":49059},"source":{"system":"sec-edgar","filing":"0001415889-18-000535","document":"form4-04032018_010417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411879/000141588918000535/form4-04032018_010417.xml","form_type":"4"}},{"id":4030022,"issuer":{"id":151567,"kind":"organization","name":"INNOVUS PHARMACEUTICALS, INC.","symbol":"INNV"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-02-27T15:02:41.000Z","date":"2018-02-23","kind":"grant","acquired":true,"shares":500000,"price":0.179,"value":89500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"RSU was granted on February 23, 2018. 125,000 RSUs vest on February 23, 2019; the total remaining shares vest in eight (8) pro rata equal installments, quarterly for two (2) years thereafter, subject to continued service."},{"field":"kind","element":"transactionCoding","label":"F3","text":"These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSU was granted on February 23, 2018. 125,000 RSUs vest on February 23, 2019; the total remaining shares vest in eight (8) pro rata equal installments, quarterly for two (2) years thereafter, subject to continued service."}],"balance_after":2218158,"derivative":{"expiration_date":"2028-02-23","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001415889-18-000328","document":"form4-02272018_120227.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411879/000141588918000328/form4-02272018_120227.xml","form_type":"4"}},{"id":4030021,"issuer":{"id":151567,"kind":"organization","name":"INNOVUS PHARMACEUTICALS, INC.","symbol":"INNV"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-02-27T15:02:41.000Z","date":"2018-02-23","kind":"grant","acquired":true,"shares":35928,"price":0.0835,"value":2999.988,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted a Restricted Stock Unit on February 23, 2018 of 35,928 shares, which were fully vested on the date of the grant.  The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the fourth quarter of 2017 and was valued on December 31, 2017 in accordance with the approved compensation plan for the non-employee members of the Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan."}],"balance_after":1718158,"derivative":{"exercise_date":"2018-02-23","expiration_date":"2028-02-23","underlying":"Common Stock","underlying_shares":35928},"source":{"system":"sec-edgar","filing":"0001415889-18-000328","document":"form4-02272018_120227.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411879/000141588918000328/form4-02272018_120227.xml","form_type":"4"}},{"id":4115135,"issuer":{"id":89101,"kind":"organization","name":"ThermoGenesis Holdings, Inc.","symbol":"THMO"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true,"officer":true,"officer_title":"COO"}}],"security":"Stock Options","published_at":"2018-01-03T16:24:45.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in five equal installments on December 29, 2018, 2019, 2020, 2021 and 2022. Under the terms of the award agreement, no portion of the option maybe exercised unless and until the stockholders of the Company approve the November 2017 amendment to our 2016 Equity Incentive Plan, and only if such amendment is approved by the stockholders within one year of the adoption of the amendment."}],"balance_after":250000,"derivative":{"exercise_price":3,"expiration_date":"2027-12-29","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001437749-18-000117","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811212/000143774918000117/rdgdoc.xml","form_type":"4"}},{"id":4197605,"issuer":{"id":151567,"kind":"organization","name":"INNOVUS PHARMACEUTICALS, INC.","symbol":"INNV"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-10-02T16:55:55.000Z","date":"2017-10-01","kind":"grant","acquired":true,"shares":32967,"price":0.091,"value":2999.997,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted a Restricted Stock Unit on October 1, 2017 of 32,967 shares, which were fully vested on the date of the grant."},{"field":"date","element":"transactionDate","label":"F3","text":"These restricted stock units were granted pursuant to the Issuer's 2016 Equity Incentive Plan."}],"balance_after":1682230,"derivative":{"exercise_date":"2017-10-01","expiration_date":"2027-10-01","underlying":"Common Stock","underlying_shares":32967},"source":{"system":"sec-edgar","filing":"0001415889-17-001597","document":"form4-10022017_011045.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411879/000141588917001597/form4-10022017_011045.xml","form_type":"4"}},{"id":4267569,"issuer":{"id":151567,"kind":"organization","name":"INNOVUS PHARMACEUTICALS, INC.","symbol":"INNV"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-07-03T06:00:19.000Z","date":"2017-07-01","kind":"grant","acquired":true,"shares":26643,"price":0.1126,"value":3000.0018,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted a Restricted Stock Unit on July 1, 2017 of 53,286 shares, which were fully vested on the date of the grant."},{"field":"kind","element":"transactionCoding","label":"F3","text":"These restricted stock units were granted pursuant to the Issuer's 2016 Equity Incentive Plan."}],"balance_after":1649263,"derivative":{"exercise_date":"2017-07-01","expiration_date":"2027-07-01","underlying":"Common Stock","underlying_shares":26643},"source":{"system":"sec-edgar","filing":"0001415889-17-001078","document":"form4-07032017_060707.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411879/000141588917001078/form4-07032017_060707.xml","form_type":"4"}},{"id":4365003,"issuer":{"id":151567,"kind":"organization","name":"INNOVUS PHARMACEUTICALS, INC.","symbol":"INNV"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-04-03T13:45:45.000Z","date":"2017-04-01","kind":"grant","acquired":true,"shares":27523,"price":0.109,"value":3000.007,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted a Restricted Stock Unit on April 1, 2017 of 27,523 shares, which were fully vested on the date of the grant."},{"field":"kind","element":"transactionCoding","label":"F3","text":"These restricted stock units were granted pursuant to the Issuer's 2016 Equity Incentive Plan."}],"balance_after":1622620,"derivative":{"exercise_date":"2017-04-01","expiration_date":"2027-04-01","underlying":"Common Stock","underlying_shares":27523},"source":{"system":"sec-edgar","filing":"0001415889-17-000572","document":"form4-04032017_100435.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411879/000141588917000572/form4-04032017_100435.xml","form_type":"4"}},{"id":4419526,"issuer":{"id":89101,"kind":"organization","name":"ThermoGenesis Holdings, Inc.","symbol":"THMO"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true,"officer":true,"officer_title":"COO"}}],"security":"Stock Options","published_at":"2017-02-28T11:50:19.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units and options vest in four equal installments: 25% on March 31, 2017, 25% on June 30, 2017, 25% on September 30, 2017 and 25% on December 31, 2017.  Under the terms of the award agreements, no portion of the option maybe exercised and no shares of stock underlying the option or restricted stock units will be issued under our 2016 Equity Incentive Plan until our stockholders approve such plan."}],"balance_after":25000,"derivative":{"exercise_price":2.89,"expiration_date":"2024-02-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-17-003401","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/811212/000143774917003401/rdgdoc.xml","form_type":"4"}},{"id":4419525,"issuer":{"id":89101,"kind":"organization","name":"ThermoGenesis Holdings, Inc.","symbol":"THMO"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true,"officer":true,"officer_title":"COO"}}],"security":"Common Stock","published_at":"2017-02-28T11:50:19.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":25000,"price":2.89,"value":72250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units and options vest in four equal installments: 25% on March 31, 2017, 25% on June 30, 2017, 25% on September 30, 2017 and 25% on December 31, 2017.  Under the terms of the award agreements, no portion of the option maybe exercised and no shares of stock underlying the option or restricted stock units will be issued under our 2016 Equity Incentive Plan until our stockholders approve such plan."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001437749-17-003401","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811212/000143774917003401/rdgdoc.xml","form_type":"4"}},{"id":4495066,"issuer":{"id":151567,"kind":"organization","name":"INNOVUS PHARMACEUTICALS, INC.","symbol":"INNV"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-01-09T06:00:20.000Z","date":"2017-01-01","kind":"grant","acquired":true,"shares":15114,"price":0.1985,"value":3000.129,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted a Restricted Stock Unit on January 1, 2017 of 15,114 shares, which were fully vested on the date of the grant."},{"field":"kind","element":"transactionCoding","label":"F3","text":"These restricted stock units were granted pursuant to the Issuer's 2016 Equity Incentive Plan."}],"balance_after":1595097,"derivative":{"exercise_date":"2017-01-01","expiration_date":"2027-01-01","underlying":"Common Stock","underlying_shares":15114},"source":{"system":"sec-edgar","filing":"0001415889-17-000045","document":"form4-01092017_060101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411879/000141588917000045/form4-01092017_060101.xml","form_type":"4"}},{"id":4546986,"issuer":{"id":151567,"kind":"organization","name":"INNOVUS PHARMACEUTICALS, INC.","symbol":"INNV"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2016-11-21T06:00:25.000Z","date":"2016-11-16","kind":"grant","acquired":true,"shares":416667,"price":0.25,"value":104166.75,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Reporting Person was granted a Restricted Stock Unit on November 16, 2016 of 416,667 shares, which was fully vested on the date of the grant."},{"field":"kind","element":"transactionCoding","label":"F3","text":"These restricted stock units were granted pursuant to the Issuer's 2016 Equity Incentive Plan."}],"balance_after":1024271,"derivative":{"exercise_date":"2016-11-16","expiration_date":"2026-11-16","underlying":"Common Stock","underlying_shares":416667},"source":{"system":"sec-edgar","filing":"0001415889-16-007483","document":"form4-11212016_061113.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411879/000141588916007483/form4-11212016_061113.xml","form_type":"4"}},{"id":4546985,"issuer":{"id":151567,"kind":"organization","name":"INNOVUS PHARMACEUTICALS, INC.","symbol":"INNV"},"owners":[{"id":27727,"kind":"person","name":"LIU VIVIAN H","position":1,"cik":"0001203467","reported_name":"LIU VIVIAN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2016-11-21T06:00:25.000Z","date":"2016-10-01","kind":"grant","acquired":true,"shares":11538,"price":0.26,"value":2999.88,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person was granted a Restricted Stock unit on October 1, 2016 of 11,538 shares, which was fully vested on the date of grant."},{"field":"kind","element":"transactionCoding","label":"F3","text":"These restricted stock units were granted pursuant to the Issuer's 2016 Equity Incentive Plan."}],"balance_after":607604,"derivative":{"exercise_date":"2016-10-01","expiration_date":"2026-10-01","underlying":"Common Stock","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001415889-16-007483","document":"form4-11212016_061113.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411879/000141588916007483/form4-11212016_061113.xml","form_type":"4"}}]}